Do cost-sharing and entry deregulation curb pharmaceutical Innovation?
Year of publication: |
2011
|
---|---|
Authors: | Grossmann, Volker |
Publisher: |
Munich : Center for Economic Studies and ifo Institute (CESifo) |
Subject: | Pharmazeutische Forschung | Forschungsfinanzierung | Kostenbeteiligung | Gesetzliche Krankenversicherung | Markteintritt | Gesundheitsökonomik | Produktivität | Neue Wachstumstheorie | Theorie | aggregate productivity | cost-sharing | entry deregulation | health insurance | pharmaceutical innovation |
Series: | CESifo Working Paper ; 3439 |
---|---|
Type of publication: | Book / Working Paper |
Type of publication (narrower categories): | Working Paper |
Language: | English |
Other identifiers: | 660775697 [GVK] hdl:10419/46570 [Handle] |
Classification: | I10 - Health. General ; L10 - Market Structure, Firm Strategy, and Market Performance. General ; O30 - Technological Change; Research and Development. General |
Source: |
-
Do cost-sharing and entry deregulation curb pharmaceutical Innovation?
Grossmann, Volker, (2011)
-
Do Cost-sharing and Entry Deregulation Curb Pharmaceutical Innovation?
Grossmann, Volker, (2011)
-
Do cost-sharing and entry deregulation curb pharmaceutical innovation?
Grossmann, Volker, (2013)
- More ...
-
Wage Effects of High-Skilled Migration : International Evidence
Grossmann, Volker, (2013)
-
Migration, Capital Formation, and House Prices
Grossmann, Volker, (2013)
-
Migration, capital formation, and house prices
Grossmann, Volker, (2013)
- More ...